GREENVILLE, S.C., Dec. 3 /PRNewswire/ -- In the United States, it is estimated that 50% of men over age 40 will suffer some form of erectile dysfunction (E.D.). Thanks to a major breakthrough in technology, there is a new alternative to expensive pills, surgery and injections ... VirimaX Gentlemen’s Briefs. With VirimaX, there is no risk of damaging side effects to achieve intimacy.
BioTech Therapies, located in Greenville, South Carolina, has recently introduced its patent-pending CMU Technology that provides the only non- pharmaceutical/non-surgical alternative for the treatment and prevention of E.D. In clinical tests over a nine-month period, hundreds of men suffering from E.D. experienced an 80% success rate using this remarkable new technology versus the 65% success rate claimed by the pharmaceutical products (Viagra, Cialis, Levitra). Importantly, no adverse side effects were recorded using the VirimaX product.
The CMUs are scientifically placed in the stylish VirimaX briefs that can be worn as replacement for regular underwear. The CMUs interact with the body’s own bio-electrical and bio-magnetic systems to restore and increase the blood flow and oxygen supply required to achieve the desired results.
Unlike the pills that cause a temporary rush of blood flow, the CMU Technology repairs, restores and energizes cells which causes the blood vessels to widen and therefore improve blood flow and oxygen to groin area on a long term basis. The advantages of wearing the VirimaX Briefs are numerous. There is no doctor’s appointment required, no prescription necessary, no possible harmful side effects, less expensive overall than pharmaceutical treatments, and far more convenient in that intimacy can be achieved at any time the situation is appropriate.
BioTech Therapies has developed an innovative program for males who would like to determine if this product will work for them. It is a sixty-day, no- risk offer referred to as the “VirimaX Challenge.” The company’s claims that this product performs as well as, or better than the pharmaceutical products, can be verified by the participant. For men wanting to enroll in this program, all of the necessary information can be found on the company’s website at http://www.virimaxbriefs.com/.
For more information contact: Neil Connor Phone (864) 527-6800 Fax (864) 527-6801
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com/.
BioTech Therapies
CONTACT: Neil Connor of BioTech Therapies, +1-864-527-6800, or fax,+1-864-527-6801
Web site: http://www.virimaxbriefs.com/